Auxilium

Contact Details: 160 W.Germantown Pike, Suite D-5 Norristown PA 19401 United States of America Tel: (610) 239 8850 Fax: (610) 239 8853 Email: WWW: www.auxiliuma2.com/

Loading...

Recent Publications by Auxilium:
BODE Index and GOLD Staging as Predictors of 1-Year Exacerbation Risk in Chronic Obstructive Pulmonary Disease. BACKGROUND:: The body mass index/airflow obstruction/dyspnea/exercise...	21st November, 2009	From the Department of Physiotherapy (mmf), Centro Universitario Catolico	Am J Med Sci. 2009 Nov 18. DOI Direct Link
Robot-mediated therapy for paretic upper limb of chronic patients following neurological injury. OBJECTIVE: To evaluate the effectiveness of robot-mediated therapy...	29th October, 2009	Neurological Rehabilitation Unit, Auxilium Vitae Rehabilitation Center,	J Rehabil Med. 2009 Nov;41(12):976-80. DOI Direct Link
Relationship between disease severity and quality of life in patients with chronic obstructive pulmonary disease. Few studies have evaluated the relationship between Airways Questionnaire...	8th July, 2009	Departamento de Fisioterapia, Centro Universitario Catolico Salesiano	Braz J Med Biol Res. 2008 Oct;41(10):860-5.
[Aortic coarctation is correlated with bicuspid aortic valve and intracranial aneurysm: a case report and review of the literature] Aortic coarctation is often linked to bicuspid aortic valve and only...	12th April, 2006	SO di Riabilitazione Cardiologica Auxilium Vitae Volterra, Ospedale di	G Ital Cardiol (Rome). 2006 Feb;7(2):151-4.

Press Releases on Auxilium:
BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Care Conference	24th November, 2009	BioSpecifics Technologies Corp.	LYNBROOK, N.Y., Nov. 24 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that
Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results	6th November, 2009	BioSpecifics Technologies Corp.	-- In its September 3, 2009 edition, The New England Journal of Medicine published data from the pivotal CORD I Phase III clinical trial of XIAFLEX for the treatment of Dupuytren
BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results	5th November, 2009	BioSpecifics Technologies Corp.	-- In its September 3, 2009 edition, The New England Journal of Medicine published data from the pivotal CORD I Phase III clinical trial of XIAFLEX for the treatment of Dupuytren
BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2009 Financial Results on November 5, 2009	30th October, 2009	BioSpecifics Technologies Corp.	LYNBROOK, N.Y., Oct. 30 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, announced today that
BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes	29th June, 2009	BioSpecifics Technologies Corp.	LYNBROOK, N.Y., June 29 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, announced today that

BioNews Results for Auxilium:
Auxilium Pharmaceuticals To Present At The Lazard Capital Markets 6th Annual Healthcare Conference; Webcast At	RTTNews.com:  Nov 18 2009 2:23PM Matching: auxilium
Auxilium Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 4:32AM Matching: auxilium
Auxilium Pharmaceuticals To Present At The Credit Suisse 18th Annual Global Healthcare Conference; Webcast At	RTTNews.com:  Nov 13 2009 2:32PM Matching: auxilium
Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference	Market Wire:  Nov 11 2009 12:14PM Matching: auxilium
Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference	Stockwatch:  Nov 11 2009 12:02PM Matching: auxilium
Promote your company here: BioNewsCast - Press Release Distribution	→View more Auxilium news.

Auxilium Clinical Trials:
AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 776 times since April 2007, the link to the organisation's website has been followed 156 times

Recent Search Terms used to find this page: Auxilium | pharmaceutical | Auxilium logo | auxilium | auxilium bulletin board | auxilium collagenase | .

Search for more companies in Norristown

Search for more companies in PA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Auxilium